Упрощенная HTML-версия
427.
Stamler J.
/ J. Stamler, J.D. Neaton // JAMA. – 2008. – Vol. 300, № 11. –
P. 1343 – 1345.
428.
Stress and hypertension / R. S. Zimmerman [et al.] // J. Hypertens. – 1990. –
Vol. 8. – P. 103-107.
429.
Stress as a Potential Modifier of the Impact of Lead Levels on Blood Pressure:
The Normative Aging Study / J.L. Peters [et al.] // Environ. Health. Perspect. –
2007. – Vol. 115, № 8. – P. 1154–1159.
430.
Stuart C. The Indelible Inseparability of Brain and Thought, of Mind and Body
/ C. Stuart, S. C. Yudofsky, R. E. Hales // Psychiatric Times. – 2004. – Vol.
XXI. – Issue 9.
431.
Summary of the 2007 European Society of Hypertension (ESH) and European
Society of Cardiology (ESC) guidelines for the management of arterial
hypertension // Vasc. Health. Risk. Manag. – 2007. – Vol. 3, № 6. – P. 783–
795.
432.
Sympathetic activation in cardiovascular and renal disease / Grassi G [et al.] //
J. Nephrol. – 2009. – Vol. 22, № 2. – P. 190 – 195.
433.
Sympathetic activity in obese subjects with and without obstructive sleep
apnea / K. Narkiewicz [et al.] // Circulation. – 1998. – Vol. 98. – P. 772-76.
434.
Sympathetic drive and vascular damage in hypertension and atherosclerosis / P.
Pauletto [et al.] // Hypertension. – 1991. – Vol. 17 (Suppl. III) . – P. 75-81.
435.
Sympathoadrenal activity in human obesity: heterogeneity of findings since
1980 / J. B. Young [et al.] // Int. J. Obes. Relat. Metab. Disord. – 1992. – Vol.
16. – P. 959-967.
436.
Szabo B. Imidazoline antihypertensive drugs: a critical review on their
mechanism of action / B. Szabo // Pharmacol Ther. – 2002. – Vol. 93. – P. 1-
35.
437.
The course of geriatric depression with «reversible dementia»: a control study /
Alexopolous G. [et al.] // Am. J. Psychiat. – 1993. – V. 150. – P. 1693-1699.